Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

• Jennifer L. Crombie,
• Caron A. Jacobson,
• Robert Redd,
• Geoffrey Shouse,
• Alex F. Herrera,
• Victor A. Chow,
• Jordan Gauthier,
• Erin Mullane,
• Kirk Cahill,
• Justin Kline,
• Jason Romancik,
• Jonathon B. Cohen,
• Anna Saucier,
• Roch Houot,
• Philippe Armand,
• Brian Hess

Affiliations

Jennifer L. Crombie

Dana-Farber Cancer Institute, Boston, MA

Caron A. Jacobson

Dana-Farber Cancer Institute, Boston, MA

Robert Redd

Dana-Farber Cancer Institute, Boston, MA

Geoffrey Shouse

City of Hope National Medical Center, Duarte, CA

Alex F. Herrera

City of Hope National Medical Center, Duarte, CA

Victor A. Chow

Fred Hutchinson Cancer Research Center, Seattle, WA; University of Washington, Seattle, WA

Jordan Gauthier

Fred Hutchinson Cancer Research Center, Seattle, WA; University of Washington, Seattle, WA

Erin Mullane

Fred Hutchinson Cancer Research Center, Seattle, WA; University of Washington, Seattle, WA

Kirk Cahill

University of Chicago, Chicago, IL

Justin Kline

University of Chicago, Chicago, IL

Jason Romancik

Emory University, Atlanta, GA

Jonathon B. Cohen

Emory University, Atlanta, GA

Anna Saucier

Dana-Farber Cancer Institute, Boston, MA

Roch Houot

University Hospital of Rennes, Rennes

Philippe Armand

Dana-Farber Cancer Institute, Boston, MA

Brian Hess

Hollings Cancer Center, Medical University of South Carolina, Charleston, SC